Mindray DS USA, Inc. dba Mindray North

Form 483 issued March 31, 2016 · Mahwah, New Jersey

Inspection
Mar 8 – Mar 31, 2016
Investigator
Li Li
Observations
1
Pages
3
FEI number
2221819

In short: On March 31, 2016, FDA issued a Form 483 with 1 observation to Mindray DS USA, Inc. dba Mindray North in Mahwah, New Jersey (FEI 2221819) after an inspection that ran Mar 8 – Mar 31, 2016. The investigator was Li Li. Most observations concern cAPA; the most-cited regulation is 21 CFR 820.198 (complaint files).

At a glance

1 of 1 observations on this 483 concern capa.

CAPA1

Most cited: 21 CFR 820.198(c) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Complaints involving the possible failure of a device , labeling and packaging to meet any of…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Mindray DS USA, Inc. dba Mindray North?

FDA listed 1 observation on this Form 483, mostly about cAPA. The most-cited regulation is 21 CFR 820.198 (complaint files). The opening words of each observation are shown on this page.

Who inspected Mindray DS USA, Inc. dba Mindray North?

Li Li is named on this Form 483, for the inspection of Mar 8 – Mar 31, 2016. Each investigator has a profile showing what they cite most.

When was Mindray DS USA, Inc. dba Mindray North inspected by FDA?

The inspection ran Mar 8 – Mar 31, 2016, and the Form 483 is dated March 31, 2016.

How do I get the full Form 483 for Mindray DS USA, Inc. dba Mindray North?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free